chrisvoncsefalvay/vaers-outcomes huggingface dataset:
10/30/2022 I had a scratchy throat. 10/31 I woke up with a headache, brain fog, scratchy throat, fatigue, loss sense of smell and taste, nausea, and diarrhea. Tested on an at home COVID-19 test, positive. Tele visit with doctor. Doctor prescribed albuterol inhaler, Z-PAK, PAXLOVID, BROMFED cough medication. By 5th day, November 5th symptoms were very reduced. After PAXLOVID, I felt better. Once PAXLOVID was out, symptoms returned and got worse. This is when the doctor proscribed the Z-PAK. Symptoms gradually improved until November 19th when I felt better. Still lingering headache, sinus and nasal drainage, with occasional nausea.
Pt recvd 3 doses of Engerix-B & it was determined that pt did not serconvert; 4th dose of Engerix-B was administered;
Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Additional Details: Patient experienced rash above R knee, R hand, L eye, R elbow.
No additional AEs were reported; The healthcare worker reported that a patient received improperly stored vaccine; This spontaneous report has been received from a health care worker concerning a 9-year-old patient of unknown gender. The patient's concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided.  On 26-AUG-2022, the patient was vaccinated with an improperly storage dose of Hepatitis A Vaccine, Inactivated (VAQTA) administered as prophylaxis, lot number W003118 with expiration date 13-JUL-2023; lot number W015191 with expiration date 27-OCT-2023 (dosage frequency and route of administration were not reported) (Product storage error). No additional adverse events were reported (No adverse event). The mentioned vaccines underwent a temperature excursion of 11.3 degrees Celsius (C) for 34 minutes, with no previous temperature excursions.
Rashes all over my body, especially on arms and legs. None of antihistamines and steroids medicines worked. They finally went away after 1.5 months with acupuncture and herb detoxification medicines.
reporting that an expired dose of MENACTRA was inadvertently given to a patient, with no reported adverse event; Initial information received on 10-MAR-2022 regarding an unsolicited valid non-serious case received from a health care professional via call center.  This case involves an infant patient with unknown demographics who experienced reporting that an expired dose of menactra was inadvertently given to a patient, with no reported adverse event while receiving vaccine Meningococcal A-C-Y-W135 (D CONJ) vaccine [MENACTRA].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included -HPV vaccine VLP RL1 4V (YEAST) (GARDASIL), Diphtheria Vaccine toxoid, pertussis vaccine Acellular 3-component, tetanus vaccine toxoid (BOOSTRIX) and Influenza vaccine inact SPLIT 3V (FLUZONE HIGH DOSE) for Prophylactic vaccination.  On 10-Mar-2022, the patient received a dose of suspect Meningococcal A-C-Y-W135 (D CONJ) vaccine (batch- U6827BA, expiry-13-FEB-2022) (dose, strength and frequency-unknown) via intramuscular route in right deltoid for prophylactic vaccination.  On 10-MAR-2022 the patient developed "reporting that an expired dose of menactra was inadvertently given to a patient, with no reported adverse event" (expired product administered) following the administration of  Meningococcal A-C-Y-W135 (D CONJ) vaccine.  Action taken:  not applicable.  At time of reporting, the outcome was Unknown for the event reporting that an expired dose of menactra was inadvertently given to a patient, with no reported adverse event.    This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
This spontaneous report as received from a registered nurse refers to an 11 year old male patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with GARDASIL, in the right arm, (dose, frequency, route of administration, lot number and expiration date were not reported). At the same time, the patient was also vaccinated with Tdap, in the left arm, (dose, frequency, route of administration, lot number and expiration date were not reported). The reporting nurse stated, that post vaccinations the patient had to be propped up by his Mom. He looked pale, feeling faint but he did not fall. As reported the patient experienced severe pain in the right arm where he received GARDASIL and severe pain in the left arm where he was vaccinated with Tdap. The nurse laid the patient down for about one hour. The patient still reported pain in the arms, but no other adverse reactions aside from that. No interventions were reported by the nurse. The reporting nurse, stated that the patient had finally got up and had walked out of the office with his parents and siblings. She also stated that she noticed that the ethnic group, as per the patient, responded that vaccinations were always paiful. The outcome of the events was unknown. The relatedness between the events and GARDASIL was not reported. Additional information has been requested.
PATIENT AWOKE SATURDAY MORNING WITH A SORE ARM AND MILD PINK AREA SURROUNDING INJECTION SITE. OVER THE WEEKEND, THE SORENESS AND REDNESS HAVE INTENSIFIED TO PAIN LEVEL OF ABOUT 3 OUT OF 10 AND PT'S DENTIST ADVISED HER TO LET US KNOW ABOUT THE REACTION. PT'S DELTOID IS RED AND WARM TO THE TOUCH, IN PYRAMID SHAPED TRIANGLE ABOUT 2.5 INCHES HIGH AND 4 INCHES ACROSS AT WIDEST POINTS.  PT DID TAKE IBUPROFEN THE OTHER DAY AND TRIED BENADRYL.  SHE STATES "I DON'T REALLY THINK IT DID ANYTHING".  AREA OF REDNESS HAS GROWN OVER THE WEEKEND.
Intussusception (bowel obstruction) 2 weeks after Rotateq vaccine given.  Vomiting, admitted surgical correction was required.  6/3/08 Reviewed hospital medical records for 4/29-5/6/2008. FINAL DX: intussception, s/p exp lap w/reduction of IS, appendectomy Records reveal patient experienced emesis x 2 days, lethargy, abdominal distention, dehydration & bloody stool.  To OR.  Progressed slowly w/bilious emesis developing post op.  Eval for recurrence of IS was neg.  Gradually improved & d/c to home.
was sick; Initial information was received on 07-Nov-2020 regarding an unsolicited valid non-serious social media case from a consumer via social media.  This case involves patient (unknown demography) who was sick (illness), while the patient received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious was sick (illness) (24 hours) following the administration of INFLUENZA VACCINE. It was reported that the patient was remained sick for 5 more days.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
Flu; Initial information received on 02-Dec-2020 regarding an unsolicited valid non-serious case from a patient via social media.  This case involves a patient of unknown demographic details who had flu (influenza), while being vaccinated with INFLUENZA VACCINE.   The patient's medical history, past medical treatment, vaccination, family history and concomitant medication were not reported.  On an unknown date, the patient received INFLUENZA VACCINE(produced by unknown manufacturer) (batch number and expiry date were not reported) at an unknown dose, via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, (latency: unknown) after being vaccinated with INFLUENZA VACCINE, the patient got the flu (influenza). The patient reported of suffering from flu when got the same every year. When the patient started receiving the same every other year then the patient reported of facing no issues.   No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was resolved on an unknown date.   There will be no information available regarding batch number in this case.
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown demographics. The patients' pertinent medical histories, drug reactions or allergies and concomitant medications were not reported. On unspecified dates, the patients received an improperly stored doses of ROTATEQ orally (dose, lot # and expiration date were not reported) for prophylaxis. The administered doses of vaccine were exposed to a temperature between 32 degrees Fahrenheit (F) and 36 degrees Fahrenheit (F), with the lowest temperature of 33 degrees Fahrenheit (F), for unknown period of time. No previous temperature excursion was reported. Data logger was used to track the temperature. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1703USA000338: US-009507513-1703USA000337: US-009507513-1703USA000336: US-009507513-1702USA009503:
can't barely walk; her ankles hurting really bad; a little bit of soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (can't barely walk), VACCINATION SITE PAIN (a little bit of soreness in her arm) and ARTHRALGIA (her ankles hurting really bad) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021 at 3:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (a little bit of soreness in her arm). On 10-Mar-2021, the patient experienced GAIT DISTURBANCE (can't barely walk) and ARTHRALGIA (her ankles hurting really bad). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, GAIT DISTURBANCE (can't barely walk), VACCINATION SITE PAIN (a little bit of soreness in her arm) and ARTHRALGIA (her ankles hurting really bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
hours after vaccine I had an episode of sweating/clammy increase HR 128 lasting for a few minutes.  The next morning has slight fever 99 but with HA and body aches and continue with increase HR 110-138 at rest. 2-3  days after symptoms continued. On 4thday continue with HA, less intense but HR remain elevated 108-136 at rest and with light activity. HR continues to be elevated 1 week later 100-132 all other symptoms have resolved, no days of work missed
Lymph node appeared on the right side on the collarbone. Its painful and cant move the arm too much.; Lymph node appeared on the right side on the collarbone. Its painful and cant move the arm too much.; Lymph node appeared on the right side on the collarbone. Its painful and cant move the arm too much.; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 12Apr2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included amitriptyline (MANUFACTURER UNKNOWN) for unspecified indication from unknown date and unknown if ongoing . The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 22Mar2021 at 12:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 16:00, the patient experienced lymph node appeared on the right side on the collarbone. It was painful and patient could not move the arm too much. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event lymph node appeared on the right side on the collarbone and it was painful and patient could not move the arm too much was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Fever of over 101 degrees for 2 days; injection site swelling and soreness, extensive body aches, joint pain, delirium, migraine
Within approximately 72 hours of receiving the Tdap vaccine my daughter developed a headache, fever, body aches, cough, congestion and running nose.  She is currently still sick but expect her to recover.
The patient received improperly stored vaccine; Information has been received from a nurse, referring to a patient of unknown age and gender. The patient's concomitant therapies included pneumococcal 13v conj vaccine (crm197) (PREVENAR 13) and hib conj vaccine (tet toxoid), diphtheria toxoid, pertussis acellular 5-component vaccine, poliovirus vaccine inactivated (mrc-5), tetanus toxoid (PENTACEL). The patient's concurrent condition and historical condition were not provided. On 27-SEP-2019, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 1 dose, orally, lot number S004251, expiration date 22-SEP-2020 for prophylaxis.   Administered dose of vaccine experienced the temperature excursion of 1.4 degrees Celsius for 20 minutes. Data logger was involved. There was previous excursion reported as 10.5 degrees Celsius for 56 minutes.
Red raised area (approx 3 1/2 ") around immunization site -  patient says its very "itchy".
Facial rash - erythema (B) cheeks & periorbital petechiae. Gave TYLENOL & BENADRYL. Monitored x 20 minutes.
caller reports skin red "like a sunburn" and is peeling/shedding; also c/o severe chapped/burning lips
All joints exftremely sore, especially right shoulder and arm. feel like joints are stiffening up. terrible cough producing yuck probably allergies though. I have a high tolerance to pain, so for me to complain, it seems worth mentioning. thanks.
Got J&J vaccine at our clinic on 4/9/21. Notes that several hours later he developed HA and hives over his abdomen. Sx got worse overnight, and by the next morning he noticed additional sx of tongue numbness/tingling, so went to the ER. ER diagnosed him with allergic reaction and discharged him with a short course of steroids and Rx for Banophen.   He notes that the symptoms returned again on 4/24/21, and again this morning 4/28/21. Went back to ER on 4/24, got more steroids and sx went away. This morning bought OTC Benadryl and sx went away when he took 50-100mg.
blacked out; lost control of the car and had an accident; I felt sluggish/dizzy and a bit nauseous/It was the same dizzy and nauseous feeling but more intense; I felt sluggish/dizzy and a bit nauseous/It was the same dizzy and nauseous feeling but more intense; I felt sluggish/dizzy and a bit nauseous/It was the same dizzy and nauseous feeling but more intense; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 07May2021 08:30 (Batch/Lot Number: EW0179) as 2nd dose, single for covid-19 immunization at a hospital. Medical history included allergy to some animal. Prior to vaccination, the patient was not diagnosed with COVID-19. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and has no other medications received within 2 weeks of vaccination. The patient had the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EN6199) on 16Apr2021 at 08:30 in the left arm for COVID-19 immunization. The patient felt sluggish/dizzy and a bit nauseous the evening of the vaccine (07May2021). The next day (08May2021 08:00), the patient felt the same way while driving. It was the same dizzy and nauseous feeling but more intense. Then a few seconds later, she blacked out, lost control of the car and had an accident. The events resulted in emergency room/department or urgent care. The patient was treated with stitches and painkillers for the injuries. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovered on May2021.  Information on Lot/Batch number was available. Additional information has been requested.
did not return to receive second dose; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 64-year-old female patient who received HAB (Twinrix) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Twinrix (1st dose received on 22nd June 2021, (lot number, expiry date unknown) via intramuscular route in the right deltoid).   On 21st September 2021, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On 21st September 2021, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The pharmacist reported that the patient did not return within the recommended time frame to receive the second dose. The second dose to be received on 21st September 2021 on the day of reporting, which would lead to lengthening of vaccination schedule. The reporter consented to follow up.
Minor was given vaccine out a age range for vaccine provided.  Patient was not honest in their paperwork and when age was verbally confirmed post vaccine.
Approximately 24 hours after pneumonia vaccine, my husband's arm swelled significantly, became very red from the shoulder to the elbow, and there was pain upon touching it.  He also began running a fever of 102 degrees.  We brought him in to the emergengy room for treatment that night.  He was treated with Prednisone, Benadryl, and Pepcid.  The physician also gave him a prescription for cephalexin, which he began taking the next day.  As of right now, 84 hours post-injection, the swelling has subsided, the redness has migrated to his forearm, and the pain is reduced.
This case was reported by a physician and described an 18 month old male pt who inadvertently received separate injections of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B recombinant and inactivated polio virus vaccine combined (Pediarix) and diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) on the same day. On 10/1/04, the pt received the 3rd dose of Pediarix. On 10/1/04, the pt also received an injection of Fluzone and Prevnar. Later that day, the pt experienced soreness at an unspecified injection site. The physician reported that no intervention was required and the pt was instructed to take ibuprofen and acetaminophen as needed to relieve soreness. Approximately 3 days later, on 10/4/04, the injection site soreness had resolved. In the physician's opinion, the soreness at an unspecified injection site was related to the erroneous administration of Infanrix.
Chicken pox rash on all torso and small fever (100-101). Fever began on Saturday 01/31 and rush on all torso begun on 02/03/2015 afternoon.
Sore night of administration then on 12/16/04, developed a 14 x 11.5 erythema macular rash over his deltoid region. No fever. Treated with cortisone cream and Zyrtec for 10 days.
Patient became dizzy upon standing and experience left sided weakness. Ambulance was called and patient transported to hospital. Upon exam it was determined the patient had a bleed on the ride side of the brain. After 4 or 5 days she was transferred to Rehab. She was then sent back to hospital after complications. Patient began having kidney problems and was undergoing dialysis. 06/16/2021 patient began having bad headaches, CT scan showed multiple previous strokes(clots). Patient currently still in hospital.
Received ZOSTAVAX vaccine Friday 12/11/15 AM SQ (L) arm. Friday night started red swelling, itch, pain at site of vaccine. Has continued to increase in size, headache, nausea and loose stools and fatigue. Today in office size of erythema 10 cm x 10 cm with central 3 x 3 cm induration and brighter erythema and tender.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient was vaccinated with ZOSTAVAX (lot# unspecified) one year ago in approximately February 2012. The patient developed redness at the injection site after receiving the dose. She also complained of increased blood pressure after receiving the dose. The onset date of the events was not reported. The outcome of increased blood pressure and redness at the injection site was reported as recovered. Additional information has been requested.
I had sore throat and low-grade fever.  The next day the sore throat got worst. On the Jan 2nd, I went and got tested for Covid-19, positive results.  The sore throat and fever keep getting worst.  Then I developed a cough.  Then on Jan 6th, I got the antibody fusion.
Patient felt very dizzy when she received the vaccine. Her husband told us that it happen before when she received shots. We are not aware of the situation when we gave her the shot since she answered NO on one of the questions on the VAR (have you ever had a reaction after receiving vaccine including faiting or felling dizzy). she was able to answer questions and we found out that she hasn't had breakfast that day. we provided coke to her. she sat for about 20 minutes and she told us that she was fine and left with her husband after 20 minutes
On October 5th began having runny nose, minor cough, sore throat. I tested myself the evening of October 6th and tested positive for COVID-19 on a home test. October the 7th I reached out to my PCP and had a virtual visit. Ran fever on 7th and 8th the highest I recorded was 101. I was prescribed Paxlovid on October 8th and symptoms are improving but still lingering. Been fever free for 2 days.
The day after receiving flu shot had tenderness at site which progressed to upper (waste to head) Rt delt to lt side. All upper body aches to point where home sick for a couple days and saw PCP. No fever or other sx just upper bodyaches
(L) arm extremely sore & hurts to move. No redness, no swelling, no rash no numbness or tingling. Referred pt to follow-up with physician.
Vomiting, nausea, fever, headache, fatigue, and body aches.